NAV® Therapeutics

  • Research
  • Preclinical
  • Clinical
  • REGENX Programs
  • Licensed Programs
  • Investigator Sponsored Programs

The Therapeutic pipeline was designed to take advantage of the central properties of
NAV® Technology:

  • Stable, long-term gene expression
  • Highly efficient rates of gene delivery
  • Efficient delivery of therapeutic genes to tissues whose cells are not actively dividing, such as the liver, retina, and brain

Types of therapeutics in the current pipeline:

  • Gene replacement/correction for inherited disorders
  • One-time delivery of biologics for acquired diseases, with stable therapeutic protein expression

To learn more about the use of NAV Therapeutics research, development and therapeutic deployment, please click on the chart below or visit our Science section.

Connect with REGENX

Learn more about our NAV® Technology. We are actively focused on building collaboration opportunities.